Human Medicines European Public Assessment Report (EPAR): Brimica Genuair, Aclidinium / Formoterol Fumarate Dihydrate, Pulmonary Disease, Chronic Obstructive, Date of Authorisation: 19/11/2014, Revision: 11, Status: Authorised

Case Medical Research
doi 10.31525/cmr-1b7df31
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Case Journals

Related search

Human Medicines European Public Assessment Report (EPAR): DuoResp Spiromax, Budesonide / Formoterol, Pulmonary Disease, Chronic Obstructive,Asthma, Date of Authorisation: 28/04/2014, Revision: 7, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Tadalafil Mylan, Tadalafil, Erectile Dysfunction, Date of Authorisation: 21/11/2014, Revision: 8, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Levetiracetam Sun, Levetiracetam, Epilepsy, Date of Authorisation: 14/12/2011, Revision: 11, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Betmiga, Mirabegron, Urinary Bladder, Overactive, Date of Authorisation: 20/12/2012, Revision: 11, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Olazax, Olanzapine, Schizophrenia,Bipolar Disorder, Date of Authorisation: 11/12/2009, Revision: 10, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Mysimba, Naltrexone / Bupropion, Obesity,Overweight, Date of Authorisation: 26/03/2015, Revision: 11, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Aripiprazole Accord, Aripiprazole, Schizophrenia,Bipolar Disorder, Date of Authorisation: 15/11/2015, Revision: 6, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Poteligeo, Mogamulizumab, Sezary Syndrome,Mycosis Fungoides, Date of Authorisation: 22/11/2018, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Ventavis, Iloprost, Hypertension, Pulmonary, Date of Authorisation: 15/09/2003, Revision: 26, Status: Authorised

Case Medical Research
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy